Understanding these tables eliminates guesswork
Preclinical studies report faster healing timelines, with tendon strength recovery observed within 14 to 28 days in controlled animal models
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial
Peak PF angle decreased during both assistive (6.59%) and resistive (15.03%) conditions, with the lowest PF values occurring during resistance
Analysis and interpretation of data: Ghaith, Johnson, Ghanem, Michaelides, Bon Nieves, Marsh, Currier, Spinner
Altogether, these data indicate that GSH is differentially important in FoB and MZB at steady state, and that MZB show higher dependency on GSH upon in vitro activation